When was Onc.ai founded?

Onc.ai was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Onc.ai located?

Onc.ai is headquartered in San Carlos, United States.

How many employees does Onc.ai have?

As of Jul 01, 2024, the latest employee count at Onc.ai is 19.

Is Onc.ai a funded company?

Onc.ai is a funded company, having raised a total of $31M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 02, 2020.

When was the latest funding round of Onc.ai?

Onc.ai's latest funding was a $***** Grant (prize money) round on Sep 13, 2024, with participation from 1 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $1.07B in funding in 2026 to date.

Where does Onc.ai rank among its competitors?

Onc.ai ranks 6th amongst 339 active competitors, of which 93 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Proscia, which secured $50M in Mar, 2025.

Who are the top competitors of Onc.ai?

Onc.ai's top competitors include PathAI, Ibex and Aignostics. Among them, Proscia secured the most recent funding round in March, 2025.

Onc.ai - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI-based cancer treatment and diagnosis platform for healthcare providers. The platform assists in the decision-making process for providing and aiding in cancer treatment decisions using AI technology, genomics, proteomics, radionics, and more.

Key Metrics

Founded Year

2020

Location

San Carlos, United States

Stage

Series A

Total Funding

$31M in 3 rounds

Latest Funding Round

Grant (prize money), Sep 13, 2024, $*****

Investors

MassMutual & 13 more

Ranked

6^th among 339 active competitors

Employee Count

19 as on Jul 01, 2024

Similar Companies

Innovaccer & 2546 more

View Onc.ai's full profile

Onc.ai has raised a total funding of $31M over 3 rounds. Its first funding round was on Dec 02, 2020. Its latest funding round was a Grant (prize money) round on Sep 13, 2024 for $*****. 1 investor participated in its latest round. Onc.ai has 10 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Onc.ai:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 13, 2024	1970170	Grant (prize money)	2173893	4828327	7596467	2447068
Jan 05, 2023	7439153	Series A	5484545	9493735	5153270	Life Extension Ventures & 4 more
Dec 02, 2020	5677209	Series A	8342697	6159678	Accomplice & 1 more	515 Ventures & 6 more

Access funding benchmarks and valuations. Sign up today!

View details of Onc.ai's funding rounds and investors

The founders of Onc.ai are Akshay Nanduri, Salmaan Ahmed and Petr Jordan.

Here are the details of Onc.ai's key team members:

Akshay Nanduri: Founder & CEO of Onc.ai and founder of 1 other company.
Contact Info: 1 email address
Salmaan Ahmed: VP Software, Founder of Onc.ai.
Petr Jordan: CTO, Founding Team Member of Onc.ai.
Contact Info: 1 email address

View details of Onc.ai's Founder profiles and Board Members

Onc.ai's employee count trend

Onc.ai has 19 employees as of Jul 24. Here is Onc.ai's employee count trend over the years:

Uncover Onc.ai's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Onc.ai include PathAI, Ibex and Aignostics. Here is the list of Top 10 competitors of Onc.ai, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Kaiser Permanente & 21 others	70/100
2nd	Ibex 2016, Tel Aviv (Israel), Series C	Provider of AI-powered diagnostic solutions for pathology	$114M	83NORTH, Octopus Ventures & 6 others	68/100
3rd	Aignostics 2018, Berlin (Germany), Series B	Provider of AI-driven solutions for drug development and precision medicine	$53.9M	Boehringer Ingelheim Venture Fund, Wellington Partners Venture Capital ... & 9 others	66/100
4th	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Casdin Capital, Goldman Sachs & 9 others	65/100
5th	Pictor Labs 2019, Los Angeles (United States), Series B	AI-based solutions for pathological image analysis	$48.8M	Insight Partners, M Ventures & 4 others	62/100
6th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Life Extension Ventures & 12 others	62/100
7th	Lunit 2013, Seoul (South Korea), Public	Developer of artificial intelligence solutions for cancer detection and treatment	$135M	InterVest, Shinhan Investment Corp & 24 others	62/100
8th	EnSpectra Health 2014, Mountain View (United States), Series A	Developer of medical devices for tissue imagining and cancer detection	$15.5M	Foothill Ventures, Heuristic Capital Partners ... & 5 others	61/100
9th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	59/100
10th	Proscia 2014, Philadelphia (United States), Series C	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, Flybridge Capital Partners ... & 22 others	59/100